EPA-E
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EPA-E, covering 2014-11-20 to 2014-11-20. Get the full timeline:
Most recent: Clinical Trial Update: Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) [Phase 2]